Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TNYA compared with ANVS: revenue, margins and what each company keeps, and the suppliers and customers both name
TNYA
Tenaya Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ANVS
Annovis Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TNYA
Tenaya Therapeutics, Inc.
vs
ANVS
Annovis Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TNYA
2
ALNY
Alnylam Pharmaceuticals
customer
—
California Institute for Regenerative Medicine (CIRM)
unlisted
supplier
Shared
0
No shared counterparties.
Only ANVS
1
—
Alzheimer's Disease Cooperative Study ("ADCS")
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
TNYA
Tenaya Therapeutics, Inc.
Change
0.36
▲
+13.96%
· post 0.36
Mkt cap
$82.1M
Revenue
$2M
Q3 FY26
ANVS
Annovis Bio, Inc.
Change
0.82
▲
+23.07%
· post 0.95
Closed
Nov 6 '26
Mkt cap
$36.0M
Revenue
—
vs
Compare
Closed
Nov 6 '26
TNYA
Tenaya Therapeutics, Inc.
vs
ANVS
Annovis Bio, Inc.
0.36
▲
+13.96%
post 0.36
Price
0.82
▲
+23.07%
post 0.95
$82.1M
Mkt cap
$36.0M
Q3 FY26
$2M
Revenue
—
Change
Change
TNYA
0.36
▲
+13.96%
vs
ANVS
0.82
▲
+23.07%
Closed
Nov 6 '26